MondayJun 02, 2025 10:00 am

Korean Researchers Develop AI to Predict Cancer Patients’ Response to Immunotherapy

A research team whose leadership is based in South Korea has developed an AI model for predicting how cancer patients will respond to immunotherapy. Designed to improve the precision of treatment in colorectal and gastric cancer, the AI model could provide physicians with a significantly more accurate tool for customizing therapies. Immunotherapy is a relatively new approach to cancer treatment that involves “training” the immune system to recognize and destroy malignant cells. In contrast to chemotherapy and radiation which can damage surrounding healthy tissue, immunotherapy allows physicians to more precisely target tumor cells. As a result, many patients undergoing immunotherapy…

Continue Reading

MondayMay 12, 2025 10:00 am

Getting a Second Opinion After Breast Cancer Diagnosis Doesn’t Delay Treatment Commencement

It is very natural to feel immense anxiety and fear after receiving a breast cancer diagnosis. Most people don't consider seeking second opinions and would rather begin treatment right away. After all, breast cancer is one of the deadliest types of cancer in women, second only to lung cancer in terms of fatalities. The Breast Cancer Research Foundation estimates that slightly over 42,000 women will die from the condition in 2025, making it one of the most prolific killers in the USA. However, researchers say that getting a second opinion after the first breast cancer diagnosis does not delay the…

Continue Reading

MondayMar 31, 2025 10:00 am

Natural Killer Cells That are Genetically Modified Show Potential in Cancer Immunotherapy

Under normal circumstances, natural killer cells in the body can detect and eliminate malignant cells. However, these NK cells can at times be unable to breach the defense mechanisms of tumors, rendering the killer cells unable to combat the growing cancer. A recent pre-clinical study suggests that natural killer cells can be tweaked in a bid to boost their ability to fight cancerous cells. This study’s findings appeared in the Nature Immunology journal and the work was a collaborative effort between several universities and companies. These included Pompeu Fabra University, Karolinska Institutet located in Sweden, a Germany-based company called Miltenyi…

Continue Reading

Contact us: (512) 354-7000